Psychiatria et neurologia paediatrica japonica
Online ISSN : 2434-1339
Print ISSN : 0559-9040
Guanfacine Improves Nocturnal Enuresis in Children with Attention Deficit Hyperactivity Disorder: Two Cases Report
Kei OHASHI
Author information
Keywords: Guanfacine
JOURNAL RESTRICTED ACCESS

2020 Volume 60 Issue 3 Pages 233-238

Details
Abstract
Enuresis is more common and treatment resistance for enuresis is higher in children with attention deficit hyperactivity disorder (ADHD) than in children showing typically normal development. Previous reports have described that medical therapy for ADHD effectively treats enuresis in these children. Case 1: A 7-year-old boy received guanfacine (1 mg) to reduce distraction, and the nocturnal enuresis rate reduced from more than 90 % to 0 % within a week. Case 2: A 13-year-old girl received guanfacine (1 mg) and methylphenidate (18 mg) to manage carelessness, and the nocturnal enuresis rate reduced from 100 % to approximately 30 % within a week. Midway awakening decreased in Case 1 and sleep onset and awakening improved in Case 2. We consider that improvement in sleep quality is associated with improvement in enuresis. Guanfacine is a useful treatment option in children with ADHD presenting with enuresis.
Content from these authors
© 2020 Japanese Society of Pediatric Psychiatry and Neurology
Previous article Next article
feedback
Top